0001214659-23-012223.txt : 20230908 0001214659-23-012223.hdr.sgml : 20230908 20230908170413 ACCESSION NUMBER: 0001214659-23-012223 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230816 FILED AS OF DATE: 20230908 DATE AS OF CHANGE: 20230908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones James CENTRAL INDEX KEY: 0001490829 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 231246017 MAIL ADDRESS: STREET 1: 2525 WEST END AVE., SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 marketforms-62531.xml PRIMARY DOCUMENT X0508 4 2023-08-16 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001490829 Jones James 1600 WEST END AVENUE, SUITE 1300 NASHVILLE TN 37203 true false false false 1 Common Stock 2023-08-16 5 L false E 65 1.64 A 27358 D Common Stock 2023-08-17 5 L false E 65 1.70 A 27423 D Common Stock 2023-08-18 5 L false E 65 1.70 A 27488 D Common Stock 2023-08-21 5 L false E 65 1.68 A 27553 D Common Stock 2023-08-22 5 L false E 65 1.72 A 27618 D Common Stock 2023-08-23 5 L false E 65 1.70 A 27683 D Common Stock 2023-08-24 5 L false E 27 1.69 A 27710 D Common Stock 2023-08-25 5 L false E 65 1.70 A 27775 D Common Stock 2023-08-28 5 L false E 65 1.71 A 27840 D Common Stock 2023-08-29 5 L false E 70 1.67 A 27910 D Common Stock 2023-08-30 5 L false E 65 1.68 A 27975 D Common Stock 2023-08-31 5 L false E 65 1.67 A 28040 D The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. James Jones by /s/ John Hamm as attorney-in-fact 2023-09-08